cyclosporine has been researched along with 2019 Novel Coronavirus Disease in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 40 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| Arora, A; Mehta, RD; Mohta, A; Srinivasa, R | 1 |
| Komiyama, K; Miyakawa, Y; Nagata, M; Naito, E; Sekiya, R; Yamazaki, S; Yogi, S | 1 |
| Clerici, M; Daniele, T; Fenizia, C; Galbiati, S; Tacchetti, C; Vago, R; Vanetti, C | 1 |
| Barrett, R | 1 |
| Ando, Y; Hayashi, I; Keino, H; Nakayama, M; Okada, AA; Watanabe, T | 1 |
| Hiraoka, T; Kondo, Y; Tsuge, M | 1 |
| Gámez-González, LB; Hamada, H; Yamazaki-Nakashimada, MA | 1 |
| Boswell, KL; Carroll, R; Darden, I; Gaudinski, M; Gordon, I; Groarke, EM; Jean-Baptiste, N; Koup, RA; Lin, BC; Lotter, J; Ma, X; McDermott, A; Moore, C; Naisan, M; Narpala, SR; Novik, L; Patel, BA; Prabhakaran, M; Rajput, RV; Rios, OJ; Serebryannyy, L; Superata, J; Trost, J; Wang, JL; Willis, J; Wu, CO; Young, NS | 1 |
| Nihei, R; Nishio, Y; Sato, T; Sora, D; Takeuchi, M | 1 |
| Abe, K; Ait-Oufella, H; Alacamli, G; Alacamli, OG; Amir, O; Antar, S; Ashour, H; Azimonti, G; Baba, Y; Balogun, MM; Bampidis, V; Bastos, ML; Ben Hamouda, N; Bickel Haase, T; Bjornsson, R; Bostan, M; Braik, R; Brantom, P; Briggs, S; Bujor, I; Canbek, TD; Cherecheanu, AP; Chesson, A; Choudhary, RJ; Christensen, H; Chung, HR; Clavier, T; Dahman, NBH; Dani, S; Demailly, Z; Devine, LD; Ding, G; Duan, X; Durjava, M; Dusemund, B; Edebali, S; Elbaz Greener, G; Elnoby, AS; Fang, Q; Fares, AM; Fashola, MB; Fawzy, MS; Fouad, FM; Fu, SZ; Fujita, S; Furusawa, S; Gallagher, AM; Gao, J; Goyal, N; Guo, J; Hamuda, N; Han, Y; Hariri, G; Heist, EK; Hill, AJ; Homoud, M; Hu, Q; Hu, Z; Huang, L; Ide, T; Ikeda, M; Ishimaru, K; Jiang, C; Kaderli, ST; Kanamura, T; Karalezli, A; Kaur, P; Kazatsker, M; Kobo, O; Kouba, M; Kumar, R; Lavillegrand, JR; Leshem, E; Li, A; Li, S; Liu, R; López Puente, S; López-Alonso, M; Ma, M; Madias, C; Manini, P; Marcon, F; Margolis, G; Matsushima, S; Mayo, B; Miller, JE; Miyake, R; Miyamoto, HD; Naumann-Gola, S; Ortner, E; Pandit, R; Pang, Y; Pechová, A; Petkova, M; Pîrvulescu, R; Popa-Cherecheanu, A; Ramos, F; Roguin, A; Rozen, G; Ruskin, JN; Sanz, Y; Schweiggert-Weisz, U; Shafie, AAA; Sharma, H; Shi, X; Stoicescu, EA; Stopyra, W; Suh, JD; Sul, S; Tamion, F; Tiu, C; Tohyama, T; Tsutsui, H; Tsutsui, Y; Vandestienne, M; Villa, RE; Wang, P; Watanabe, M; Westendorf, J; Woutersen, R; Xia, J; Xing, W; Xu, X; Yang, L; Yang, N; Yu, J; Yu, M; Yu, X; Zhang, L; Zhao, Y; Zhao, Z; Zhou, X; Zorn, H | 1 |
| Li, P; Liu, C; Lu, W; Ma-Lauer, Y; Su, Z; von Brunn, A; Wu, A; Yang, F; Zhang, H; Zhu, D | 1 |
| Li, L; Li, W; Liu, H; Liu, L; Nashan, B; Ning, L; Shen, A; Wang, J; Yao, Z; Zhang, S; Zhao, D | 1 |
| Benotmane, I; Caillard, S; Fafi-Kremer, S; Gautier, G; Marx, D; Moulin, B; Perrin, P | 1 |
| Duan, Q; Feng, S; Guo, L; Li, J; Liu, J; Liu, X; Luo, W; Wang, L; Wu, Y; Xie, M; Yang, Q; Zhu, R | 1 |
| Liu, W; Sun, L; Tian, L | 1 |
| Ahmed-Belkacem, A; Ahnou, N; Berry, F; Brillet, R; Bruscella, P; Fourati, S; Hamadat, S; Morin-Dewaele, M; Nevers, Q; Pawlotsky, JM; Softic, L | 1 |
| Axelrad, J; Chang, S; Hudesman, D; Rosen, MH; Rubin, DT | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Pawlotsky, JM | 1 |
| Cumhur Cure, M; Cure, E; Kucuk, A | 1 |
| Di Lernia, V; Feliciani, C; Goldust, M | 1 |
| Argaud, L; Cour, M; Ovize, M | 1 |
| Fischereder, M; Guba, MO; Kemmner, S; Schönermarck, U; Stangl, M | 1 |
| de la Higuera, MAM; Fornie, IS; Franci, EV; Hurtado, M; Lucena, R; Moreno, AR; Rodriguez-Cubillo, B; Romero, NC; Sanchez-Fructuoso, AI; Valencia, D; Velo, M | 1 |
| Khurana, A; Sethia, K | 1 |
| Agnes, S; Bianco, G; Graceffa, D; Lai, Q; Lerut, J; Rossi, M; Spoletini, G | 1 |
| Brun, P; Dubois, J; Dulière, V; Julien, T; Lina, B; Padey, B; Pizzorno, A; Rosa-Calatrava, M; Terrier, O; Traversier, A | 1 |
| Abdollahimajd, F; Ghalamkarpour, F; Pourani, MR; Zargari, O | 1 |
| Han, M; Meng, F; Wei, J; Zhao, J; Zhou, J | 1 |
| Blomberg Jensen, M; Hornum, M; Poulsen, NN; von Brunn, A | 1 |
| Aparicio-Hernández, D; Ávila-Morales, J; Cabrera-Estrada, AA; Cisneros-Méndez, S; Cortés-Díaz, G; Cortés-Sánchez, V; Cruz-Delgado, C; Deveaux-Homs, J; Flores-Encarnación, SE; Gálvez-Romero, JL; Gómez-Pluma, MÁ; Navarro-González, J; Olivos-Rodríguez, R; Palmeros-Rojas, O; Pedraza-Sánchez, S; Ramírez-Sandoval, MP; Real-Ramírez, FA; Reyes-Inurrigarro, S; Rodríguez-Rivas, DI; Sánchez-Romero, S; Sarmiento-Padilla, G; Tezmol-Ramírez, SE; Tome-Maxil, R; Urbina-Sánchez, MI | 1 |
| Baillie, JK; Clohisey, S; Head Fourman, M; Law, A; Millar, JE; Parkinson, N; Rodgers, N; Russell, CD; Swets, MC; Wang, B; Zechner, M | 1 |
| Ahamad, S; Gupta, D; Kanipakam, H; Kumar, V; Prasad, K | 1 |
| Antolí, A; Corbella, X; Niubó, J; Padullés, N; Rocamora-Blanch, G; Solanich, X; Videla, S | 1 |
| Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
| Heo, YA | 1 |
| Ayyanathan, K; Cardenas-Diaz, FL; Castellana, L; Cherry, S; Dittmar, M; Jurado, K; Kamalia, B; Lee, JS; Li, M; Morrisey, EE; Ramage, H; Samby, K; Schultz, DC; Segrist, E; Truitt, R; Whig, K; Yang, W | 1 |
| Dash, S; Mishra, S; Sirka, CS; Viswan, P | 1 |
| Aylı, M; Caliskan, E; Coban, SN; Esme, P; Ugur, B | 1 |
7 review(s) available for cyclosporine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
[Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].
Topics: Antiviral Agents; Betacoronavirus; Coronavirus; Coronavirus Infections; COVID-19; Cyclophilin A; Cyclosporine; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Virus Replication | 2020 |
Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
Topics: Abortion, Spontaneous; Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Clinical Laboratory Techniques; Colitis, Ulcerative; Coronavirus Infections; COVID-19; COVID-19 Testing; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Pandemics; Patient Acuity; Pneumonia, Viral; Pregnancy; Pregnancy Complications; Remission Induction; SARS-CoV-2; Sigmoidoscopy; Treatment Outcome | 2020 |
SARS-CoV2 and immunosuppression: A double-edged sword.
Topics: Calcineurin Inhibitors; COVID-19; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Male; Pandemics; SARS-CoV-2; Steroids; Tacrolimus; Transplant Recipients | 2020 |
Cyclosporine and COVID-19: Risk or favorable?
Topics: COVID-19; COVID-19 Drug Treatment; Cyclosporine; Humans; Immunocompromised Host; Immunosuppressive Agents; Pandemics; SARS-CoV-2 | 2020 |
Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19.
Topics: Algorithms; CD3 Complex; CD4 Antigens; Chemokine CXCL10; Computational Biology; COVID-19; Cyclophilin A; Cyclosporine; Databases, Genetic; Genome-Wide Association Study; Genomics; Humans; Immune System; Immunogenetics; Inflammation; Interleukin-1alpha; Microtubule-Associated Proteins; Proteomics | 2020 |
Voclosporin: First Approval.
Topics: Animals; Calcineurin Inhibitors; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Approval; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Nephritis | 2021 |
2 trial(s) available for cyclosporine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Topics: Adolescent; Adult; Animals; Asthma; Atrial Fibrillation; Autoantibodies; Biomarkers; Breast Neoplasms; Child; Conjunctivitis, Allergic; Cornea; COVID-19; Cyclosporine; Cytokines; Death, Sudden, Cardiac; Defibrillators, Implantable; Diet; Disease Models, Animal; Docetaxel; Double-Blind Method; Dry Eye Syndromes; Educational Status; Emulsions; Female; Fluorescein Angiography; Fluoresceins; Focus Groups; Heart Failure; Hemothorax; Humans; Inflammation; Keratoconus; Male; Meibomian Glands; Mice; Middle Aged; Multiple Sclerosis; Myocardial Infarction; Myocardium; Nerve Fibers; Nigeria; Obesity; Overweight; Pandemics; Primary Prevention; Prospective Studies; Qualitative Research; Registries; Retinal Ganglion Cells; Retinal Vessels; Schools; Sirolimus; Tertiary Care Centers; Th1 Cells; Th2 Cells; Tomography, Optical Coherence; Troponin I; Tumor Necrosis Factor-alpha; United States; Ventricular Remodeling | 2022 |
Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study.
Topics: COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lung; Male; Methylprednisolone; Middle Aged; Pilot Projects; Prednisone; Treatment Outcome | 2021 |
32 other study(ies) available for cyclosporine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |
Recurrent herpes zoster after COVID-19 vaccination in patients with chronic urticaria being treated with cyclosporine-A report of 3 cases.
Topics: Chronic Urticaria; COVID-19; COVID-19 Vaccines; Cyclosporine; Herpes Zoster; Humans; SARS-CoV-2; Vaccination | 2021 |
Pure red cell aplasia accompanied by COVID-19 successfully treated using cyclosporine.
Topics: Aged; Anemia, Hemolytic, Autoimmune; COVID-19; Cyclosporine; Humans; Male; Red-Cell Aplasia, Pure; SARS-CoV-2 | 2022 |
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Topics: Anti-Inflammatory Agents; Antiviral Agents; COVID-19; Cyclosporine; Cytokine Release Syndrome; Cytokines; Humans; Lung; SARS-CoV-2; Virus Release | 2022 |
Calcineurin inhibitors and related medicines: a cohort study examining England's primary care prescription changes during the COVID-19 pandemic (January 2019 to March 2021).
Topics: Calcineurin Inhibitors; Cohort Studies; Communicable Disease Control; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Pandemics; Prescriptions; Primary Health Care; Sirolimus; Tacrolimus | 2022 |
A COVID-19 Risk Reduction Strategy for the Treatment of Acute Vogt-Koyanagi-Harada Disease Utilizing the Antiviral Potential of Cyclosporine.
Topics: Aged; COVID-19; Cyclosporine; Glucocorticoids; Humans; Pandemics; Retrospective Studies; Triamcinolone Acetonide; Uveomeningoencephalitic Syndrome | 2023 |
Cyclosporine for the treatment of multisystem inflammatory syndrome in children with coronary artery aneurysms.
Topics: Child; Coronary Aneurysm; Coronary Vessels; COVID-19; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Interleukin 1 Receptor Antagonist Protein; Mucocutaneous Lymph Node Syndrome; Systemic Inflammatory Response Syndrome | 2022 |
Cyclosporin for treatment of refractory multisystemic inflammatory syndrome in a child.
Topics: Abdominal Pain; Administration, Intravenous; Child; COVID-19; Cyclosporine; Diarrhea; Humans; Male; Syndrome | 2023 |
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
Topics: Anemia, Aplastic; COVID-19; COVID-19 Vaccines; Cyclosporine; Humans; Immunity; Immunosuppressive Agents; Recurrence; SARS-CoV-2; Vaccination | 2022 |
Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.
Topics: BNT162 Vaccine; CD8-Positive T-Lymphocytes; COVID-19; COVID-19 Vaccines; Cyclosporine; Epitopes; HLA-DR4 Antigen; Humans; Male; Middle Aged; Panuveitis; RNA, Messenger; SARS-CoV-2; Uveomeningoencephalitic Syndrome | 2022 |
Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2-Induced Inflammation.
Topics: COVID-19; Cyclophilin A; Cyclosporine; Humans; Inflammation; SARS-CoV-2 | 2023 |
Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report.
Topics: Adrenal Cortex Hormones; Adult; Betacoronavirus; China; Coronavirus Infections; COVID-19; Cyclosporine; Disease Outbreaks; Drug Combinations; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Lopinavir; Male; Pandemics; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Transplant Recipients; Treatment Outcome | 2020 |
First case of COVID-19 in a kidney transplant recipient treated with belatacept.
Topics: Abatacept; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lung; Male; Middle Aged; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Prednisone; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Prevention and Control of COVID-19 in Chronic Kidney Disease.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Interferon-alpha; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Renal Insufficiency, Chronic; SARS-CoV-2 | 2020 |
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
Topics: Animals; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Cyclophilins; Cyclosporine; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
COVID-19 Pandemic: Time to Revive the Cyclophilin Inhibitor Alisporivir.
Topics: Animals; Antiviral Agents; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Cyclophilins; Cyclosporine; Disease Models, Animal; Humans; Mice; Rats; SARS-CoV-2 | 2020 |
Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19).
Topics: Coronavirus Infections; COVID-19; Cyclosporine; Cytokines; Humans; Immunosuppressive Agents; Pandemics; Pneumonia, Viral; Sodium-Hydrogen Exchangers | 2020 |
Covid-19 infection in psoriasis patients treated with cyclosporin.
Topics: Adolescent; Adult; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Psoriasis; SARS-CoV-2; Young Adult | 2020 |
Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
Topics: Acute Disease; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Pandemics; Pneumonia, Viral; Respiratory Insufficiency; Treatment Outcome | 2020 |
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
Topics: Betacoronavirus; Calcineurin; Calcineurin Inhibitors; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Kidney Transplantation; Pandemics; Pneumonia; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2?
Topics: Aged; Aged, 80 and over; Comorbidity; COVID-19; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Pandemics; Renal Insufficiency; Retrospective Studies; SARS-CoV-2; Spain; Transplant Recipients | 2020 |
Using cyclosporine in the COVID era: An emergent need for caution.
Topics: COVID-19; Cyclosporine; Humans; Immunosuppressive Agents; Pandemics; SARS-CoV-2 | 2020 |
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Berberine; Betacoronavirus; Chlorocebus aethiops; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Antagonism; Drug Combinations; Drug Repositioning; Drug Synergism; Humans; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells | 2020 |
A case of severe psoriatic erythroderma with COVID-19.
Topics: COVID-19; Cyclosporine; Dermatitis, Exfoliative; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2 | 2022 |
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Topics: Adult; Antibodies, Viral; Betacoronavirus; Coronavirus Infections; COVID-19; Cyclosporine; Cytokines; Fatal Outcome; Humans; Immunity, Cellular; Immunity, Humoral; Immunocompromised Host; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; T-Lymphocytes, Cytotoxic | 2020 |
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine.
Topics: Antiviral Agents; Cathepsin B; Cathepsin L; COVID-19; Cyclosporine; Drug Repositioning; Humans; Immunosuppressive Agents; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Pandemics; SARS-CoV-2; Serine Endopeptidases; Virus Internalization | 2021 |
Inhibition of SARS-CoV-2 replication using calcineurin inhibitors: are concentrations required clinically achievable?
Topics: Antiviral Agents; Calcineurin Inhibitors; COVID-19; Cyclosporine; Humans; Pilot Projects; SARS-CoV-2; Steroids; Virus Replication | 2021 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2.
Topics: Animals; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Repositioning; Epithelial Cells; Humans; Lung; SARS-CoV-2; Serine Endopeptidases; United States; United States Food and Drug Administration; Vero Cells | 2021 |
COVID-19 vaccine-induced Stevens-Johnson syndrome.
Topics: Administration, Oral; COVID-19; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Male; Middle Aged; SARS-CoV-2; Skin; Stevens-Johnson Syndrome; Treatment Outcome | 2021 |
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.
Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy | 2021 |